Norepinephrine Sopharma (Noradrenaline Tartrate)

Noradrenaline Tartrate, the active ingredient in Norepinephrine Sopharma, is a sympathomimetic amine presented as an intravenous solution for use in acute care settings. It acts as a potent vasopressor to raise blood pressure in patients with severe hypotension, such as those experiencing septic or cardiogenic shock.

GNH USA supplies Norepinephrine Sopharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to health‑care institutions across multiple regions and ensures timely delivery.

Norepinephrine is a vasopressor used in critical care to manage life‑threatening hypotension.

Septic shock: restores arterial pressure and improves organ perfusion. Cardiogenic shock: supports cardiac output while maintaining systemic vascular resistance. Post‑operative hypotension: stabilizes blood pressure during anesthesia emergence.

Norepinephrine may produce a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects: - Tachycardia: increased heart rate due to β1 stimulation. - Hypertension: excessive rise in blood pressure from α1 vasoconstriction. - Headache: vascular changes may trigger cranial discomfort. - Anxiety or restlessness: central adrenergic activation.

Serious or Rare Side Effects: - Myocardial ischemia: reduced coronary perfusion from high afterload. - Severe arrhythmias: ventricular tachycardia or fibrillation. - Peripheral tissue necrosis: extravasation at infusion site causing ischemic injury.

When using norepinephrine, clinicians should observe specific safety measures to minimize risks.

- Blood pressure monitoring: continuously assess arterial pressure and adjust infusion rate. - Cardiac rhythm surveillance: watch for tachyarrhythmias and ischemic changes. - Dose titration: start low and increase gradually to reach target mean arterial pressure. - Contraindications: avoid in patients with pheochromocytoma or uncontrolled hypertension. - Caution in myocardial ischemia: use only if benefits outweigh risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with other agents, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive pressor effects. - Ergot alkaloids: severe vasospasm.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt β1 effects, requiring higher doses. - Other vasopressors (e.g., phenylephrine): combined pressor effect may cause excessive hypertension. - Calcium channel blockers: may affect vascular tone and require monitoring.